Submissions from 2025
The meta-analysis and systematic review mirage: when data synthesis becomes data distortion, Alessandro Villa
The Role of Adjuvant Radiation Therapy in Treating Older Breast Cancer Patients With Low Adherence to Endocrine Therapy, Ana Sandoval Leon
The Role of MR Guided Radiation Therapy in Pancreatic Cancer Treatment, Michael Chuong
Tip of the Iceberg or the Whole Titanic: Discrepant Representation of Glioblastoma on Different Imaging Modalities, Omer Gal and Rupesh Kotecha
Toward the standardization of radiopharmaceutical therapies: a technical note evaluating a clinical dosimetry workflow for single-time-point (177)Lu SPECT/CT-based therapies, Vivek Mishra, Santiago Aguirre, and Siju George
Unraveling the Crimson puzzle: Two case reports/case series of hemorrhagic cystitis after combination chemotherapy with docetaxel, carboplatin, trastuzumab and pertuzumab in breast cancer, Grace Wang, Yolcar Chamorro, and Ana Sandoval-Leon
Unraveling the Effects of Radiotherapy on the Blood Brain Barrier: Fact or Fiction?, Rupesh Kotecha and Minesh Mehta
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas, Minesh Mehta
Submissions from 2024
Financial barriers and inequity in medical education in India: challenges to training a diverse and representative healthcare workforce, Manmeet Ahluwalia
Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors, Muni Rubens and Venkataraghavan Ramamoorthy
Comparison of Stereotactic Radiosurgery and Hypofractionated Radiosurgery for Vestibular Schwannomas: A Meta-Analysis of Available Literature, Manmeet Ahluwalia
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma, Manmeet Ahluwalia
HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study, Reshma Mahtani
Multicenter retrospective cohort study of the sequential use of antibody drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2 low metastatic breast cancer (MBC): a subgroup analysis of next generation sequencing results., Reshma Mahtani, Mehmet Zerey, Ana Cristina Sandoval Leon, Lauren Carcas, Joseph Panoff, and Manmeet Ahluwalia
Multi-Institutional Quality Improvement on HER2-Positive and HER2-Low Metastatic Breast Cancer, Reshma Mahtani
Sequencing Sacituzumab Govitecan (SG) AfteR Trastuzumab Deruxtecan (T-DXd) In ER+/HER2 LOW MetaStatic Breast Cancer, Reshma Mahtani, Ana Cristina Sandoval Leon, Maria Abreu, and Manmeet Ahluwalia
Evaluation of a Partial Single Arc For Prostate SBRT Proton Treatment Planning According To RTOG 0938 Protocol, Suresh Rana
A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis, Geoffrey Young
Association between high risk of obstructive sleep apnea and inflammatory markers in a population sample of young and middle-aged adults in the Miami Heart Study, Atulya Khosla, Khurram Nasir, Anshul Saxena, Theodore Feldman, Jonathan Fialkow, Harneet Walia, Javier Valero-Elizondo, and Shozab Ali
Beyond “C”: A Nurse Navigator-Led Education Project to Increase Survivorship Referrals and Cancer Survivorship Attendance, Carem Irma Costa Castro, Morgan Nestingen, Tania Silva Santos, Pamela DeLongchamp, Luz Morales, Barbara Quintana, Marguerite Rowell, Merly Alonso, and Natalie Bermudez
Evaluation of a non-metallic dual-port expander for intensity modulated proton therapy, Kristen McConnell, Zachary Fellows, James Kraus, Mauricio Acosta, Joseph Panoff, Eduardo Pons, Alonso Gutierrez, and Andrew Wroe